News

Select Category
Tuesday 25th January 2011

New venture receives investment from the Mercia Fund

Description
The Native Antigen Company (NAC) has been formed following a spin-out from PsiOxus, formerly Hybrid BioSystems, itself a university of Birmingham Spin-out.
Date:
Tuesday 25th January 2011
Categories:
Alumni, Medical and Dental Sciences, Research
Wednesday 15th December 2010

University of Birmingham vaccine technology is rising star in new biotech company

Description
University of Birmingham spin-out company, Hybrid BioSystems, Ltd. (Hybrid), and Myotec Therapeutics, Ltd. (Myotec) today announced their merger to form PsiOxus Therapeutics, Ltd. (PsiOxus), a new, development stage biotechnology company using non-traditional approaches to novel therapeutics for cancer and wasting diseases.
Date:
Wednesday 15th December 2010
Categories:
Medical and Dental Sciences, Research
Displaying 13 to 14 of 14
Previous 1 2 3 4 Next